Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.50 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.50 |
| ▸ | NPFFR1 | Q9GZQ6 | 1/20 | 0.50 |
| ▸ | NPFFR2 | Q9Y5X5 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19862065 | 1.00 | OPRM1 (0.50) | OPRM1OPRD1OPRK1NPFFR1NPFFR2 | |
| SCHEMBL17413435 | 0.91 | CCKBR (0.46) | — | |
| SCHEMBL21627096 | 0.90 | CTSL (0.54) | OPRM1OPRD1OPRK1NPFFR1NPFFR2 | |
| SCHEMBL16862485 | 0.90 | CTSL (0.54) | OPRM1OPRD1OPRK1NPFFR1NPFFR2 | |
| SCHEMBL19861963 | 0.90 | CTSL (0.54) | — | |
| SCHEMBL19862013 | 0.90 | CTSL (0.54) | — | |
| Hydrochloric Acid SCHEMBL16862473 | 0.89 | CTSL (0.53) | OPRM1OPRD1OPRK1NPFFR1NPFFR2 | |
| SCHEMBL19862399 | 0.88 | NPY4R (0.52) | OPRM1 | |
| SCHEMBL18048887 | 0.88 | NPY4R (0.52) | OPRM1 | |
| SCHEMBL19862098 | 0.88 | NPY4R (0.52) | OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12037414-B2 | Processes for preparing pharmaceutically relevant peptides | STEALTH BIOTHERAPEUTICS INC. (US) | 2024-07-16 | — | — | US | disclosed |
| US-20180044378-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | STEALTH BIOTHERAPEUTICS INC. | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180044378-A1 | PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES | ADM2, VIP, PEPD | OPRM1 1092/4885OPRD1 1708/4885OPRK1 2236/4885 |
| US-12037414-B2 | Processes for preparing pharmaceutically relevant peptides | ADM2, VIP, PEPD | OPRM1 1092/4885OPRD1 1708/4885OPRK1 2236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.